Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

chanelle pharmaceuticals manufacturing limited - polymyxin b sulfate - unknown - polymyxin b sulfate antibiotic active 0.0 - active constituent

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - polymyxin b sulfate; prednisolone acetate; miconazole nitrate - misc. aural, ophthalmic, oro/naso pharyngeal - polymyxin b sulfate antibiotic active 0.696 mg/ml; prednisolone acetate steroid-glucocorticoid active 5.0 mg/ml; miconazole nitrate triazole active 23.0 mg/ml - ear,nose,throat preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - ear mange mite | infections of the skin | otitis externa | abscesses | acute canine otitis | anal sacculitis | associated with yeast &/or bac | chronic canine otitis | ear mites | fungal | gingivitis | gram negative bacteria | gram positive bacteria | malassezia pachydermatis | otitis (canine) | post-parturient infections | pyoderma | septicaemia | yeast

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - polymyxin b sulfate neomycin sulfate hydrocortisone - ear drops suspension - 10000 iu/ml

Nova Zelanda - anglès - Ministry for Primary Industries

zoetis new zealand limited - zinc bacitracin; polymyxin; neomycin sulphate - zinc bacitracin 8.12 g/kg; polymyxin 1.35 g/kg; neomycin sulphate 5 g/kg - antibiotic

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - oxytetracycline hydrochloride; polymyxin b sulphate -

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

pliva pharma limited - polymyxin b sulfate bacitracin zinc - unknown

Malta - anglès - Medicines Authority

laboratoire innotech international 22 avenue aristide briand, arcueil 94110, france - polymyxin b, sulfate, nystatin, neomycin sulfate - vaginal capsule - polymyxin b sulfate 35000 iu nystatin 100000 iu neomycin sulfate 35000 iu - gynecological antiinfectives and antiseptics

Estats Units - anglès - NLM (National Library of Medicine)

stat rx usa llc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Estats Units - anglès - NLM (National Library of Medicine)

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product

Estats Units - anglès - NLM (National Library of Medicine)

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infect